NSE ScannerChemicals · Chemicals: Specialty · NSE: DAICHI · data 2026-10-31
Dai-Ichi Karkaria Limited
In plain words
Price: 17.4% below its 52-week high of ₹380.
Delivery: 89.1% of traded shares were kept for delivery over the last 10 sessions, against 82.3% over the last 60.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹180 cr |
| Net profit (last 12 months) | ₹2 cr |
| Sales growth, 3 years (yearly) | -4.3% |
| Profit growth, 3 years (yearly) | — |
At a glance
P/E 107.8, dividend yield 0.5%. Price relative to earnings and book value (low is cheaper, not better).
ROE -0.4%, ROCE -3.1%, operating margin -1.2%: how much profit it earns on the money it uses.
Debt/equity 0.07, Profit growth — and sales growth -4.3% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
- Virtually debt-free (debt/equity 0.1 or less).
- Low return on equity (-0.4%).
- Thin operating margin (-1.2%).
- Expensive on earnings (P/E 107.8).
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Smart-money activity
5/100 · Weak over the last ~60 sessions, data 2026-10-30
- Delivery vs usual 0/30: Too few delivery days to compare delivery % (0 of 10); shares delivered not comparable (0 of 12); 0 delivery-spike days (3x usual shares delivered, 40%+ delivery) in the last 20 sessions.
- Bulk/block deals 0/20: No bulk or block deals in the last 90 days.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Dividend
- 20 Aug 26Dividend Dividend ₹1.5 (ex-date) +0.7% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Common questions
Is Dai-Ichi Karkaria Limited debt-free?
Its latest reported debt-to-equity ratio is 0.07, which is very low.
What is Dai-Ichi Karkaria Limited's P/E ratio?
About 107.8, based on the last 12 months' earnings and a price of ₹314 (data 2026-10-31).
What is the 52-week high and low of Dai-Ichi Karkaria Limited?
The 52-week high is ₹380 and the 52-week low is ₹229.9.
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Dai-Ichi Karkaria Limited | ₹314 | ₹235 cr | 107.8 | — | -0.4% | -3.1% | 0.07 | +21.3% |
| AksharChem India Ltd. | ₹376.95 | ₹300 cr | 10.5 | 1 | -0.2% | -3.4% | 0.41 | +34.0% |
| Sayaji Industries Limited | ₹109 | ₹290 cr | 11.1 | 2.7 | 1.5% | 10.6% | 2.45 | -12.8% |
| Arvee Laboratories (India) Ltd. | ₹206.71 | ₹228 cr | 56.2 | — | 7.8% | 5.7% | 0.03 | +27.6% |
| Ducol Organics & Colours Ltd. | ₹115 | ₹208 cr | 25.9 | 1.9 | 7.7% | 11.1% | 0.44 | -38.8% |
| IVP Ltd | ₹181.13 | ₹190 cr | 5.9 | — | 12.6% | 18.6% | 0.42 | +10.6% |
Compare DAICHI with AKSHARCHEM in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open DAICHI in NSE Scanner →